EXTENT OF THE ACUTE-PHASE RESPONSE IN FULMINANT HEPATIC-FAILURE

被引:44
|
作者
IZUMI, S
HUGHES, RD
LANGLEY, PG
PERNAMBUCO, JRB
WILLIAMS, R
机构
[1] UNIV LONDON KINGS COLL HOSP, INST LIVER STUDIES, LONDON, ENGLAND
[2] UNIV LONDON KINGS COLL, SCH MED & DENT, INST LIVER STUDIES, LONDON SE5 9PJ, ENGLAND
关键词
D O I
10.1136/gut.35.7.982
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The extent of the acute phase response and the relation between acute phase proteins and cytokines in plasma was investigated in 50 patients with fulminant hepatic failure. On admission, C reactive protein was significantly higher in fulminant hepatic failure (median: 12.4 mu g/ml, range: 0.2-112 mu g/ml) than in 20 controls (median: 0.8 mu g/ml, range: 0.3-2.9 pg/ml, p<0.001). Serial measurements showed that plasma C reactive protein increased daily after admission until day 5, the end of the study period. alpha(1)-Antitrypsin (AAT) (median: 69.1%, range: 27.5-124%) and fibrinogen (median: 1.10 g/l, range: 0-2.82 gn) were significantly lower in fulminant hepatic failure on admission than in controls (AAT: median: 126%, range: 75.4-149%; fibrinogen: median 2.48 g/l, range: 1.82-3.39 g/l, p<0.001) and did not change subsequently. Both AAT and fibrinogen were maintained at significantly higher concentrations in survivors than in those who did not. Bacterial infection occurred in 23 patients during the course of fulminant hepatic failure, but did not influence the concentrations of these three proteins. Interleukin 6 was significantly higher in fulminant hepatic failure (median: 21.2 pg/ml, range: 0-871 pg/ml) than in controls (median: 2.4 pg/ml, range: 1.5-8.2 pg/ml, p<0.001). There was a significant correlation between interleukin 6 and the C reactive protein concentrations in patients with viral hepatitis on admission and in all patients 48 hours later, consistent with other evidence that interleukin 6 stimulates synthesis of this acute phase protein.
引用
收藏
页码:982 / 986
页数:5
相关论文
共 50 条
  • [1] ACUTE-PHASE RESPONSE AFTER LIVER-TRANSPLANTATION FOR FULMINANT HEPATIC-FAILURE AND CIRRHOSIS
    IZUMI, S
    HUGHES, RD
    LANGLEY, PG
    PERNAMBUCO, JRB
    WILLIAMS, R
    [J]. TRANSPLANT INTERNATIONAL, 1995, 8 (05) : 340 - 345
  • [2] ACUTE FULMINANT HEPATIC-FAILURE
    WIESNER, RH
    [J]. TRANSPLANTATION PROCEEDINGS, 1991, 23 (03) : 1892 - 1894
  • [3] FULMINANT HEPATIC-FAILURE
    LIDOFSKY, SD
    [J]. CRITICAL CARE CLINICS, 1995, 11 (02) : 415 - 430
  • [4] FULMINANT HEPATIC-FAILURE
    TYGSTRUP, N
    RANEK, L
    [J]. CLINICS IN GASTROENTEROLOGY, 1981, 10 (01): : 191 - 208
  • [5] FULMINANT HEPATIC-FAILURE
    KATELARIS, PH
    JONES, DB
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 1989, 73 (04) : 955 - 970
  • [6] FULMINANT HEPATIC-FAILURE
    MARTIN, P
    PAPPAS, SC
    [J]. DIGESTIVE DISEASES, 1990, 8 (03) : 138 - 151
  • [7] FULMINANT HEPATIC-FAILURE
    FINGEROTE, RJ
    BAIN, VG
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1993, 88 (07): : 1000 - 1010
  • [8] FULMINANT HEPATIC-FAILURE
    RUSSELL, GJ
    FITZGERALD, JF
    CLARK, JH
    [J]. JOURNAL OF PEDIATRICS, 1987, 111 (03): : 313 - 319
  • [9] FULMINANT HEPATIC-FAILURE
    HETZEL, DJ
    [J]. ANAESTHESIA AND INTENSIVE CARE, 1985, 13 (03) : 272 - 282
  • [10] FULMINANT HEPATIC-FAILURE
    RIEGLER, JL
    LAKE, JR
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 1993, 77 (05) : 1057 - 1083